November 21, 2024 /

PPMD: 30 Years of Progress

by: Parent Project Muscular Dystrophy

1 year ago

You may also like

Introducing PPMO – Sarepta Therapeutics (May 2018)

Introducing PPMO – Sarepta Therapeutics (May 2018)

8 years ago

Research & Clinical Trial Webinars,

Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018)

Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018)

8 years ago

Research & Clinical Trial Webinars,

NS Pharma's Exon 53 Skipping Program Update (April 2018)

NS Pharma’s Exon 53 Skipping Program Update (April 2018)

8 years ago

Research & Clinical Trial Webinars,

Gene Therapy: A Closer Look (March 2018)

Gene Therapy: A Closer Look (March 2018)

8 years ago

Research & Clinical Trial Webinars,

Pulmonary Care in Adults with Duchenne (March 2018)

Pulmonary Care in Adults with Duchenne (March 2018)

8 years ago

Positive Data from Summit's PhaseOUT DMD Ezutromid Clinical Trial (February 2018)

Positive Data from Summit’s PhaseOUT DMD Ezutromid Clinical Trial (February 2018)

8 years ago

Research & Clinical Trial Webinars,

Italfarmaco Provides Givinostat Update (January 2018)

Italfarmaco Provides Givinostat Update (January 2018)

8 years ago

Research & Clinical Trial Webinars,

Understanding Gene Therapy, Part 3 - Galgt2 and Dup2 (December 2017)

Understanding Gene Therapy, Part 3 – Galgt2 and Dup2 (December 2017)

8 years ago

Research & Clinical Trial Webinars,

«1…55 565758 59…65 »

Page 57 of 65

Join Our Mailing List